Prevalence of risk determinants for metformin-associated lactic acidosis and metformin utilization in the Study of Health in Pomerania

Hormone and Metabolic Research

Volumn 40, Issue 7, 2008, Pages 491-497

  Runge, S ^a   Alte, D ^a   Baumeister, S E ^a,b   Volzke H ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b IFT INSTITUT FÜR THERAPIEFORSCHUNG   (Germany)

Author keywords

Lactic acidosis; Metformin; Prevalence

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; DIET THERAPY; DRUG UTILIZATION; ECHOCARDIOGRAPHY; FEMALE; GERMANY; HEART FAILURE; HUMAN; INTERVIEW; LABORATORY TEST; LACTIC ACIDOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ACIDOSIS, LACTIC; ADULT; AGED; ALGORITHMS; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HEALTH; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PATIENT SELECTION; PREVALENCE; RISK FACTORS;

ANGINA;

EID: 48349128164     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065319     Document Type: Article

References (31)

1. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-865
2. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ 2003; 326: 4-5
3. Fantus IG. Metformin's contraindications: needed for now. CMAJ 2005; 173: 505-507
4. Kirpichnikov D, MacFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med 2002; 137: 25-33
5. Holstein A, Stumvoll M. Contraindications can damage your health-is metformin a case in point? Diabetologia 2005; 48: 2454-2459
6. Runge S, Mayerle J, Warnke C et al. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation? Diabetes Obes Metab 2008; 10: 91-93
7. Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care 1997; 20: 925-928
8. Horlen C, Malone R, Bryant B et al. Frequency of inappropriate metformin prescriptions. JAMA 2002; 287: 2504-2505
9. Cohen RD, Woods HF. Metformin and lactic acidosis. Diabetes Care 1999; 22: 1010-1011
10. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2003; 163: 2594-2602
11. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane database of systematic reviews (Online) 2006; CD002967
12. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999; 22: 925-927
13. Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD. Contrain-dications to metformin therapy in patients with type 2 diabetes-a population-based study of adherence to prescribing guidelines. Diabet Med 2001; 18: 483-488
14. Holstein A, Nahrwold D, Hinze S, Egberts EH. Contra-indications to metformin therapy are largely disregarded. Diabet Med 1999; 16: 692-696
15. MacCormack J, Johns K, Tildesley H. Metformin's contraindications should be contraindicated. CMAJ 2005; 173: 502-504
16. Tahrani A, Varughese G, Scarpello J, Hanna F. Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ 2007; 335: 508-512
17. John U, Greiner B, Hensel E et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001; 46: 186-194
18. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367
19. Köhler E. Ein- und zweidimensionale Echokardiografie mit Dopplertechnik. Stuttgart: Ferdinand Enke Verlag 1992
20. Miller-Davis C, Marden S, Leidy NK. The New York Heart Association Classes and functional status: what are we really measuring? Heart Lung 2006; 35: 217-224
21. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2 ed. Geneva: WHO 1982
22. Alte D, Luedemann J, Rose HJ, John U. Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP). Alcohol Clin Exp Res 2004; 28: 931-940
23. Alte D, Lüdemann J, Piek M et al. Distribution and dose response of laboratory markers to alcohol consumption in a general population: results of the study of health in Pomerania (SHIP). J Stud Alcohol 2003; 64: 75-82
24. Völzke H, Robinson DM, Schminke U et al. Thyroid function and carotid wall thickness. The Journal of clinical endocrinology and metabolism 2004; 89: 2145-2149
25. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002; 162: 434-437
26. Rakovac I, Jeitler K, Gfrerer RJ et al. Patients with type 2 diabetes treated with metformin: prevalence of contraindications and their correlation with discontinuation. Diabet Med 2005; 22: 662-664
27. Kennedy L, Herman WH. Renal status among patients using metformin in a primary care setting. Diabetes Care 2005; 28: 922-924
28. Misbin RI. The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 2004; 27: 1791-1793
29. Eurich DT, Majumdar SR, MacAlister FA, Tsuyuki RT, Johnson JA. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 2005; 28: 2345-2351
30. Wysowski DK, Armstrong G, Governale L. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001. Diabetes Care 2003; 26: 1852-1855
31. Fischbacher CM, Bhopal R, Unwin N, White M, Alberti KG. The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK. Int J Epidemiol 2001; 30: 1009-1016